Reference

1. Nikhil D. Amnerkar, Bhoomendra A. Bhongade, Kishore P. Bhusari, arabjc.2014.11.0342)Rerambiah,
2.  L.K., Ndong, J.C., Massoua, P.M.M., Mezegue, S.,Elisee-Ndam, M., Mintsa-Ndong, A., Siawaya, J.F.D., 2014. Int. J.Infect. Dis. 29, 48–53.
3. Varshney, V., Mishra, N.N., Shukla, P.K., Sahu, D.P., 2009. Bioorg.Med. Chem. Lett. 19, 3573–3576.
4. Ananda Kumar, C.S., Vinaya, K., Chandra, J.N., Thimmegowda,N.R., 2008. J. Enz. Inhib. Med. Chem. 23, 462–469.
5. Sangshetti, J.N., Nagawade, R.R., Shinde, D.B., 2009. Bioorg. Med.Chem. Lett. 19, 3564–3567.
6. Zitouni, G.T., Demirayak, S., Ozdemir, A., Kaplancikli, Z.A., Ylidiz,M.T., 2003. Eur. J. Med. Chem. 39, 267–272.
7. Mahran, M.A., William, S., Ramzy, F., Sembel, A.M., 2007. Molecules12, 622–633
8. Amnerkar, N.D., Bhusari, K.P., 2011. J. Enz. Inhib. Med. Chem. 26,22–28.
9. Jimonet, P., Audiau, F., Barreau, M., Blanchard, J., 1999. J. Med.Chem. 42, 2828–2843.
10. http://www.who.int/infectious-disease-report/2002/pdfversion/ChoIntroduction.pdf a2012 may11; 2319-2400
11. WHO Wkly .Epidemol .Rec .2001; 76; 74 -76 
12. Griffith RK ,Anthelimintics In : Donald j; Abraham editors , Burger,s medicinal chemistry and drug discovery 6th.ed, A john wiley and sons .Indian,publication .2003;6;1090-1093. 
13. Rang HP ,Dale MM Rritterjm ,Flower RJ Anthelimintics In ;Rang and Dale,  pharmacology ,6 th ed  Churchill Livingstone , p.712-17. 
14. Lynne s. Garcia, Classification of Human Parasites, Vectors and Similar Organisms .Clinical Infections Diseases 16:614 -615. 
15. Lemke TL, Antiparasitic agents In Williams David A, and lemke Thomas L, ` Foye principle of Medicinal Chemistry 5th ed .New delhi, Lippincott Williams, and Wilkins, 2006; 879-885.
16. Morgana JAT ,Dejonga  RJ , Kazibweb F, Mkojic GM,  and Lokar ES,. A newly identified linkage of Schistostosoma. International Journal parasitolb 2003; 33 (9); 977-985. 
17. Hunter GW , Swartzwelder JC , Clyde DF , Ab Manual of Tropical Medicine , 5th ed , Wb Saunders  Philadelphia . 1976-june 4 129-189
18. 18.Platt HM , Foreword In S,. lorenzen , The Phy logenetic Systematic  of Free-living  Nematades . The Roy Society ,London . 1994  jan 14;383 -356. 
19. Williams BS, VandeBerg JL, Subedi J. Genes ,on Chromnosomes 1 and 13 have signiticant effect on Ascaris infecation. Proc Natl Acad Sci USA . 2002 ; 99 (8) ; 5533-8  : 10.1073 / 08219. 
20. http:/en.  Wikipedia. Org/wila/ ascariasis. Retried on 4 march  201;. 567 - 678. 
21. Cook, Gordan C, Zumla, Alimuddin I , Manson,s , tropical diseases. Saunders Elsveir 2009;22:1515-1519 .Retried 18 nov 2009; 2315-1450. 
22. Gutierrez Y, Diaganostic pathology  of parasitic infection with Clinical correlations . 2thed , Oxford University press ,2000;354-366
23. Beayer PC , Jung RC , Cupp EW , Clinical parasitological , Philadelphia ,Lea and Fibiger .1984 sept 13.,1120-1289.
24. http;//www .medterms.com /scripts/main/art 2016; 1340-17.
25. Roberts, Larry S, John., Foundation of Parasitoid of Partasitology, New York: McGraw Hill, 2005: 405-407.
26. http;//en Wikipedia.org/wiki/Filariasis retrieved March 2008., 4320-4432 .
27. Burke Joan, Research animal scientist. Management of barber’s pole worm in sheep and goats in the southern US, USDA, ARS, Deale Burmpers Small  Farms Research Center, Boonevile, AR, Wikipedia 1988 Feb 23,. 3467-1345.
28. Newton S,  Progress on vaccination of Haemonchus contortus.  International Journal of Parasitological 1995;25:1281-1289.
29. Haemonchuus, Ostertagia, and Trichostrongylus spp, the Merck Veternary manual 2006. Retrived 2007-07-01 ;1256-1268.
30. http://animaldiverstiy.ummz.umich.edu/site/accounts/information.Haemonchus_c ontortus.html.2016-06-08 ;134-456.
31. http.//www.goole.co.in/images?hl=en&source=imghp&q=life+cycleof+haemonchus+contortus 2017-11-23., 3210-4320.
32. Trpathi K D, Anthelmintic in: essential of medical pharmacology, 5th ed.  Japee others medical publishers (pvt.) limited, New delhi., 2003;759-766.
33. Geary TG, Sangster NC, Thompson DP,  Frontiers in anthelmintic  pharmacology.  Vet Parasite ,1999;84;131:97_108.
34. Beale JM.,  Anti-infective agents; Anthelmintics In: Block John M,  editors, Wilson and Gisvold’s ,Textbook of Organic Medical and Pharmaceutical Chemistry, 11th ed.  Lippincott Williams, and wilkins, 1998-2000,264-267.
35. Baheti KG, Kuberkar SV, Synthesis and biological activity of 4H-pyrimido [2,1-b] benzothiazole-8-substituted-2-thiomethyl-3-cyano-4-ones. Indian journal Heterocycl Chem 2003 April-June;12:343-678.
36. Srivastava SK, Yadav R, Srivastava SD, Synthesis and biological activity of 4-oxothiazolidines and their 5-arylidenes. Indian J Chem 2004 Feb;43B :399-405.
37. Mohd A, Faizul A, Synthesis and biological evaluation of some 4-thiazolidinones. Indian J Heterocycl Chem 2004 Oct-Dec;14:119-220.
38. Sridevi C, Balaji K, Naidu A, Kavimani S, Venkappayya D, Suthakaran R et al. Synthesis of some phenylpyrazolonzothiazolo quinoxaline derivatives. International        ournal of Pharm Tech Research 2009 July-Sept;1(3):816-21.
39. Hemendra PS, Sharma CS, Chandra PG. Synthesis and characterization of some novel pyrimido [2,1-b] benzothiazole-4-ones of biological interest. Middle-East Journal siceance Research 2009;4 (3): 203-10.
40. Mistry KM, Desai KR., Synthesis of novel heterocyclic 4-thiazolidinone derivatives and their antibacterial activity. European Journal Chem 2004 July;1(4):189-93.
41. Sandhya B, Harish K, Synthesis 6-fluoro-2-[4-formyl-3-(substituted phenyl) pyrazol-1-yl] benzothiazoles as potential antimicrobial agents. Indian Journal Heterocycl Chem 2005 Jan-March;14:249-50. 
42. Vineeta S, Vineeta K, Prakash J, Kanti S. Synthesis of 2-(6-fluorobenzothiazole-2?yl amino)-4-(phenylthiureido)-6-(substituted thiureido)-1,3,5 triazine as antimicrobial agent. Indian J Chem 2006 May;45B:1288-90.
43. Srivastava SD, Sen JP, Synthesis and biological evolution of 2-aminobenzothiazole derivatives. Indian  Journal Chem 2008 Oct;47B:1583-603.
44. Paola V, Athina G, Matteo I, Franca Z, John D, Mark H. 2-Heteroarylimino-5-benzylidene-4-thiazolidinones analogues of 2-thiazolylimino-5-benzylidene-4- thiazolidinones with antimicrobial activity: Synthesis and structure–activity relationship. Bioorg Med Chem 2008;16: 3714-24.
45. Shikha G, Neha A, Naveen G, Rajni S, Gautam DC. Novel synthesis and biological activity study of pyrimido[2,1-b] benzothiazoles. Indian Journal Chem 2009 June;48B:853-70.
46. Ivica S, Pavol Z, Peter M, Helena B, Synthesis and study of new antimicrobial benzothiazoles substituted on heterocyclic ring. Arkivoc 2009;(viii):183-92.
47. Amir M, Arun K, Israr I, Khan S,. Synthesis of pharmaceutically important 1,3,4-thiadiazole and imidazolinone derivatives as antimicrobials. Indian Journal Chem 2009 Sept;48B :1288-93.
48. Ravindra MK, Ingle VN, Synthesis of novel benzothiazole and benzisoxazole functionalized unsymmetrical alkanes and study of their antimicrobial activity. Indian Journal Chem 2009 July;48 B: 996-1000.
49. Varma RR, Athlekar SV, Patil LS, Bobade AS, Chowdhary AS, Synthesis and biological activity of some substituted benzothiazoles. Indian Journal Heterocyclic Chem 2009 April-June;18:415-60.
50. Iro A, Athina G, Paola V, Franca Z, Synthesis and biological evaluation of sulfonamide thiazole and benzothiazole derivatives as antimicrobial agents. Arkivoc 2009;(vi):89-102.
51. Jitender KM, Manvi FV, Nanjwade BK, Sanjiv S, Synthesis and anti-microbial activity of some new 2-amino substituted benzothiazole derivatives. Journal Pharmacy Research 2009;2(9):1383-40.
52. Sunder S, Praveen S, Akash Y, Muttu CT, Ranjeeta V,. Microwave assisted synthesis of fluoro, chloro, 2-N (substituted schiff’s bases) amino benzothiazoles as potential antimicrobial and antitubercular agents. The Pharma Research 2009;01..,1432-41.
53. Rajeeva B, Srinivasulu N, Shantakumar SM. Synthesis and antimicrobial activity of some new 2-substituted benzothiazole derivatives. E-J Chem 2009;6(3):775-9.
54. Samir B, Walid F, Mohamed AM, Enaminonitrile in heterocyclic synthesis: antimicrobial evaluation of some new pyrazole, isoxazole and pyrimidine derivatives incorporating a benzothiazole moiety European Journal Med Chem 2009;1-6 ., 1349-50.
55. Rekha R, Makrandi J,  Microwave assisted synthesis and antimicrobial activity of some 2-(benzofuran-2-yl)-7-(substituted) imidazo[2,3-b] benzothiazoles. Indian  Journal Chem 2009 Nov;48B: 1614-7.
56. Arasampattu SN, Kamalaraj S, Muthumary J, Reddy BO, Reddy SR. Synthesis biologically active benzothiazole substituted thiazolidinones derivatives via cyclisation of unsymmetrical imines. Indian J Chem 2009 November;48B: 1577-82.
57. Anshu J, Makrandi JK, Microwave assisted synthesis and antibacterial properties of some 2-(6?-substituted coumarino)-6-substitutedimidazo[2,1-b] benzothiazoles. Indian J Chem 2009 Jan-March;18: 301-02.
58. MinW, Mingzhang G, Bruce HM, Kathy DM, George WS et al. Synthesis of carbon-11 labeled ?uorinated 2-aryl benzothiazoles as novel potential PET cancer imaging agents. Bioorg Med Chem 2006;(14):8599–607.
59. Tashfeen AS, Najima AM, Roberta L. In vitro antitumor and antiviral activities of new benzothiazole and 1,3,4-oxadiazole-2-thione derivatives. Acta Pharm 2008;(58):135–49.
60. Stefania A, Geoffrey W, Erica LS, Hachemi K, Rana B, David RB et al. Synthesis and biological properties of Benzothiazole, Benzoxazole, and Chromen-4-one analogues of the potent antitumor agent 2-(3,4-Dimethoxyphenyl)-5-?uorobenzothiazole(PMX 610,NSC 721648)1C. International Journal Med Chem 2008;51:5135-9..
61. Manjula SN, Malleshappa NN, Vipan PK, Manohara R, Vijay R, Andanappa KG, Gurdial S. Synthesis and antitumor activity of optically active thiourea and their 2-amino benzothiazole derivatives: a novel class of anticancer agents. European Journal Med Chem 2009;(:44)2923–94.
62. Mahfuz A, Nadeem , Synthesis of new benzothiazole incorporated sulphonamidess as potential anticonvulsants. Indian Journal Heterocycl Chem 2004 Apr-Jun;13:361-4.
63. Nadeem S, Surendr NP, Suroo AK, James S, Arpana R, Mahfuz A,  Faiz A,. Synthesis and anticonvulsant activity of sulfonamide derivatives–hydrophobic domain. Bioorg Med Chem Lett 2007;(17):255–89.
64. Nadeem S, Arpana R, Suroor AK, Mashooq AB, Syed EH, et al. Synthesis  benzothiazole semicarbazones as novel antivconvulsants- The role of hydrophobic domain., Bioorg  Med Chem Lett 2007;(17):4178-82.
65. Arpana R, Nadeem S, Suroor A, Syed E, Mashooq A. N-{[(6-Substituted-1,3-benzothiazole-2-yl)amino]carbonothioyl}-2/4-substituted benzamides :synthesis and pharmacological evaluation. European  Journal of Med Chem 2008;44:1114-22.
66. Nadeem S, Arpana R, Suroor AK, Syed EH, Shamsher A, Waquar A. et al. Anticonvulsant and toxicity evaluation of newly synthesized 1-[2-(3,4-disubstituted phenyl)-3-chloro-4-oxoazetidin-1-yl]-3-(6-substituted-1,3-benzothiazol-2-yl)ureas . Acta Chim ,2009;56:462-95.
67. Nikhil D, Amnekar, Kishere PB, Synthesis, anticonvulsant activity and 3D-QSAR study of some prop-2-eneamido and 1-acetyl-pyrazolin derivatives of aminobenzothiazole. European  Journal Med Chem 2009:1-11 .,356-145.
68. Sreenivasa GM, Jayachandran E, Shivakumar B, Jayaraj KK, Vijay K. Synthesis of bioactive molecule fluoro benzothiazole comprising potent heterocyclic moieties for anthelmentic activity. Arch Pharma  Sci Res 2009 October;1(2):150-7.
69. Mohammad SY, Zaheen HA. Synthesis and in vivo diuretic activity of biphenyl benzothiazole-2-carboxamide derivatives. Acta Poloniae Pharmaceutical & Drug Research 2009;66(4):387-92.
70. Paramashivappa P, Phani KP, Subbarao PV, Srinivasa RA. Design, synthesis and biological evaluation of benzimidazole/benzothiazol and benzoxazole derivatives as cyclooxygenase inhibitors. Bioorg Med Chem Letters 2003;(13):657–60.
71. Jagabandhu D, James L, Robert VM, Zhongqi S, Steven HS, John W et al. Molecular design, synthesis, and structure-activity relationships leading to the potent and selective p56lck inhibitor BMS-243117. Bioorg Med Chem Lett 2003;13:2145-94.